• 1
    Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol 1995;173: 10491057.
  • 2
    Reznik R. Intrauterine growth restriction. Obstet Gynecol 2002;99: 490496.
  • 3
    Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344: 12221231.
  • 4
    Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340: 913.
  • 5
    Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 2000;79: 963967.
  • 6
    van Pampus MG, Dekker GA, Wolf H, et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999;180: 11461150.
  • 7
    Wienerroither H, Steiner H, Tomaselli J, Lobendanz M, Thun-Hohenstein L. Intrauterine blood flow and long-term intellectual, neurologic and social development. Obstet Gynecol 2001;97: 449453.
  • 8
    Vossbeck S, de Camargo OK, Grab D, Bode H, Pohlandt F. Neonatal and neurodevelopmental outcome in infants born before 30 weeks gestation with absent or reversed end-diastolic velocities in the umbilical artery. Eur J Pediatr 2000;160: 128134.
  • 9
    Hadlock FP, Harrist RB, Martinez-Poyter J. In utero analysis of fetal growth: a sonographic weight standard. Radiology 1991;181: 129133.
  • 10
    Kramer MS, Plat RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001;108: E35.
  • 11
    Simchen MJ, Beiner ME, Strauss-Liviathan N, et al. Neonatal outcome in growth-restricted versus appropriately grown preterm infants. Am J Perinatol 2000;138: 187192.
  • 12
    Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very low birth weight infants with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182: 198206.
  • 13
    Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in placenta. J Matern-Fetal Med 1998;7: 277286.
  • 14
    Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupferminc MJ. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol 2001;98: 10411044.
  • 15
    Peeters LL. Thrombophilia and fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2001;95: 202205.
  • 16
    Martinelli P, Grandone E, Colaizzo D, et al. Familial thrombophilia and the occurrence of fetal growth restriction. Hematologica 2001;86: 428431.
  • 17
    Snijders RJ, Sherrod C, Gosden CM, Nicolaides KH. Fetal growth retardation: associated malformations and chromosome abnormalities. Am J Obstet Gynecol 1993;168: 547555.
  • 18
    Sickler GK, Nyberg DA, Soahey R, Luthy DA. Polyhydramnios and fetal intrauterine growth restriction: ominous combination. J Ultrasound Med 1997;16: 609614.